LivaNova PLC Files Definitive Proxy Statement
Ticker: LIVN · Form: DEFA14A · Filed: Jun 6, 2024 · CIK: 1639691
| Field | Detail |
|---|---|
| Company | Livanova PLC (LIVN) |
| Form Type | DEFA14A |
| Filed Date | Jun 6, 2024 |
| Risk Level | low |
| Pages | 10 |
| Reading Time | 12 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting, sec-filing
Related Tickers: LIVN
TL;DR
LivaNova PLC just dropped its proxy statement, shareholders need to vote!
AI Summary
LivaNova PLC filed a Definitive Proxy Statement (DEFA14A) on June 6, 2024. This filing is related to the company's annual shareholder meeting and the solicitation of proxies. The document details information relevant to shareholders for voting on company matters.
Why It Matters
This filing provides shareholders with essential information to exercise their voting rights at the company's annual meeting, impacting corporate governance and strategic decisions.
Risk Assessment
Risk Level: low — This is a standard regulatory filing (DEFA14A) for a public company, typically related to annual meetings and proxy solicitations, and does not inherently indicate new risks.
Key Players & Entities
- LivaNova PLC (company) — Registrant
- 0001104659-24-068779 (filing_id) — Accession Number
- 20240606 (date) — Filing Date
FAQ
What type of SEC filing is this document?
This document is a DEFA14A, which is a Definitive Proxy Statement filed by LivaNova PLC.
Who is the filer of this document?
The filer is LivaNova PLC, as indicated by the 'Registrant' designation.
When was this filing submitted to the SEC?
The filing was submitted on June 6, 2024.
What is the purpose of a DEFA14A filing?
A DEFA14A filing is a Proxy Statement filed with the SEC, typically used to solicit proxies from shareholders for an upcoming meeting.
What is LivaNova PLC's Standard Industrial Classification (SIC) code?
LivaNova PLC's SIC code is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
Filing Stats: 2,950 words · 12 min read · ~10 pages · Grade level 12.4 · Accepted 2024-06-05 20:25:52
Filing Documents
- tm2416550d1_defa14a.htm (DEFA14A) — 32KB
- tm2416550d1_defa14aimg001.jpg (GRAPHIC) — 340KB
- tm2416550d1_defa14aimg002.jpg (GRAPHIC) — 321KB
- 0001104659-24-068779.txt ( ) — 944KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under §240.14a-12 LivaNova PLC (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 EXP LANATORY NOTE On April 26, 2024, LivaNova PLC (the “Company”) filed its definitive proxy statement and notice of Annual General Meeting (the “Proxy Statement”) with the Securities and Exchange Commission (“SEC”) in connection with the Company’s 2024 Annual General Meeting of Shareholders (“AGM”) to be held on June 11, 2024. This supplement (the “Supplement”) to the Proxy Statement is being filed to add Proposal No. 12, which is a non-binding, advisory vote on the frequency of holding an advisory vote on the compensation of the Company’s named executive officers, which is required by SEC rules to be included every six years. Specifically, the Company is asking its shareholders to vote, on a non-binding, advisory basis, with respect to the frequency of holding an advisory vote on executive compensation, as described herein. The recommendation of the Company’s Board of Directors (the “Board”) is that the Company continue to hold such an advisory vote on an annual basis and that the shareholders therefore vote for a frequency of “1 YEAR”. Other than the changes described in this Supplement, which adds Proposal No. 12 and makes other conforming changes to the Proxy Statement, no other changes have been made to the Proxy Supplement carefully and in its entirety together with the Proxy Statement. A form of the revised proxy card reflecting the addition of Proposal No. 12 has also been included in this filing. LivaNova PLC 20 Eastbourne Terrace London W2 6LG, United Kingdom Supplement to the Proxy Statement and Notice for the 2024 Annual General Meeting of Shareholders to be held Tuesday, June 11, 2024 On April 26, 2024, LivaNova PLC (the “Company”) filed its definitive proxy statement and notice of Annual General Meeting (the “Proxy Statement”) with the Securities and Exchange Commission (“SEC”) in connection with the Company’s 2024 Annual General Meeting of Shareholders (“AGM”) to be held on June 11, 2024. Subsequent to that date, the Company determined that it had inadvertently omitted a required proposal to shareholders related to the frequency of future advisory votes regarding the compensation of the Company’s named executive officers. This Supplement has been prepared to provide our shareholders with information regarding a new Proposal No. 12, a non-binding, advisory vote regarding the frequency with which the Company’s shareholders shall have the advisory, non-binding say-on-pay vote on compensation paid to its named executive officers. This Supplement is being furnished to our shareholders of record at the close of business on April 15, 2024, the record date for the determination of shareholders entitled to attend the AGM. This Supplement supplements and amends the Proxy Statement, dated April 26, 2024, previously made available to our shareholders. This Supplement does not provide all of the information that is important to your decision at the AGM. Additional information is included in the Proxy Statement that was previously made available to our shareholders. We encourage you to carefully read this Supplement together with the Proxy Statement . We urge shareholders of record to vote on Proposals 1 through 12 by following the methods described in the Proxy Statement. Please note that, if you vote again, it will revoke all proxies previously submitted. Accordingly, it is important to indicate your vote on each proposal. If you are a shareholder of record and you execute and return a new proxy but do not give instructions, your proxy will be voted “FOR” all nominees set forth in Proposal 1, “FOR” Proposals 2-11 and “1 YEAR” for Proposal 12. If you have already voted and do not take further action, your previously submitted proxy will be voted at the AGM with respect to Proposals 1-11 but will not be counted in determining the outcome of Proposal 12. Except for the addition of Proposal No. 12, this Supplement does not modify, ame